If ever there was an area of medical
practice that should get things right 100% of the time IVF Service Providers would
have to be right up there – not that I am encouraging mistakes elsewhere!
The following reveals perfection is
a pretty high bar to reach!
‘Weird and icky feeling’: Anxiety for parents after
Monash IVF embryo bungles
Two embryo
mix-ups by Monash IVF have shaken confidence in the assisted reproductive
technology sector. What does it mean for the future of IVF?
Stephen Lunn
5:00AMJune
13, 2025
Radio host
Jase Hawkins may have summed up the feelings of many parents or prospective
parents this week when he spoke about the latest embryo mix-up by leading fertility clinic Monash
IVF, its second reported bungle in the past two months.
After telling
listeners he and his partner had conceived their youngest child, Archie, with
the help of Monash IVF, Hawkins opened up about hearing news of the error.
“As someone
who’s gone through it (IVF), like, it was such a personal experience,” he told
his audience on Nova 100 FM. “And whatever company you go through … there’s
that trust you have. And yesterday was just that weird, just that icky feeling
in your guts.”
Putting
yourself in the hands of a fertility clinic to help have a child is a big step,
likely born of previous disappointment and heartache. Hope, faith, trepidation,
anxiety, daring to dream.
And then the
process itself can be gruelling. Injections to stimulate ovaries to help the
production of eggs. Egg retrieval. Sperm samples. It’s hard to imagine a health
service more intimate.
“In
reproductive care, trust is everything,” University of South Australia
bioethicist Hilary Bowman-Smart says. “Patients entrust clinics with embryos
that may represent their only opportunity to have children.
“This
(latest) mix-up – the second reported incident at Monash IVF – risks shaking
confidence, not just in one provider but across the entire fertility sector.”
So what
exactly has happened?
On Tuesday
morning Monash IVF, a listed company and one of Australia’s biggest fertility
operators, informed the Australian Securities Exchange it had implanted the
wrong embryo in a patient.
The statement
said the company had mistakenly transplanted the patient’s own biological
embryo back to her, rather than her carrying her partner’s embryo, which was
what the couple had requested in their treatment plan. The error occurred on
June 5 at a clinic in Clayton in Melbourne’s southeast.
Inquirer
understands that it should have been picked up through an electronic checking
process but wasn’t due to the two women having the same surname. It is
understood the electronic process was designed for heterosexual couples.
The
distressing error compounded another heartbreaking mistake Monash was forced to make
public just two months ago, where a woman in Brisbane had carried and then
given birth to a child conceived through IVF before learning she had been
mistakenly implanted with another couple’s embryo.
The tragic
mix-up was uncovered when the birth parents requested the transfer of their
remaining frozen embryos to another assisted reproductive therapy provider and
the clinic found there were more than there should have been.
It is
understood the baby was conceived in 2023 and the parents were informed of the
mistake in February this year, meaning they had cared for the baby for several
months. Monash IVF didn’t report the matter to the ASX until it became public
through the press in April.
Both sets of
parents are understood to be devastated about this botched transplant.
The baby’s future has not been made public. But under family
law provisions it is the birth parents who are considered the legal parents of
the baby, meaning the biological parents have no legal claim. Whether that is
the situation that has played out in this case is not known.
Monash IVF
has apologised to the affected families in both incidents and has included the
latest Melbourne issue in the scope of an independent review already being
conducted into the Brisbane matter. After the first incident it described the
mix-up as an isolated incident and the result of “human error”.
But that has
not been enough for the company’s shareholders or its board. The two embryo
mix-ups come after a mishandled genetic testing program that led to Monash IVF
last year paying $56m to settle a class action brought on behalf of more than
700 people. The program was suspended in 2020 after it was discovered that
faulty results might have meant healthy embryos were unnecessarily discarded.
The company’s
share price sat at $1.42 in August 2024, dropped from $1.08 to 67c on the day
the first embryo bungle was reported, and dropped again from 75c to 55c after
the second mix-up was declared.
On Thursday
the company notified the ASX in a brief statement that the board had accepted
the resignation of its chief executive, Michael Knaap, effective immediately. He had been in the
role since 2019.
“Since his
appointment in 2019 Michael has led the organisation through a period of
significant growth and transformation, and we thank him for his years of
dedicated service,” the statement said.
That may well
not be the end of the matter, as governments are not happy either. State and
federal health ministers urgently included the regulation of the assisted
reproductive technology sector on the agenda of their meeting on Friday and the
Victorian government has ordered its own investigation.
“These cases
are just shocking, deeply distressing, and undermine confidence in the system,”
federal Health Minister Mark Butler told ABC radio on Thursday.
“As
governments, we’ve got a responsibility to see whether there are better levels
of regulation that should be put in place and to inject some confidence back
into a system that delivers such joy to so many thousands of families every
year.”
Victorian
Health Minister Mary-Anne Thomas said families should be confident they were
receiving the highest standard of fertility treatment and “it is clear Monash
IVF has failed to deliver that, which is completely unacceptable”.
Thomas said
Victoria’s Health Regulator would be conducting its own investigation into the
latest incident.
The
ministers’ discussion will focus on whether IVF, currently subject to
nationally consistent clinical standards but regulated through state and
territory laws, should be moved to a nationally consistent federal framework.
Government
and company investigations are one thing, human responses another. The
fertility community is large. There were around 100,000 IVF cycles carried out
in Australia in the past year alone. It includes prospective users thinking
about their options, patients with embryos awaiting transplant and parents with
children born through IVF who put their faith in the system. And it includes
the many medical, technical and nursing staff in the industry.
The experts
will point to how incredibly rare events such as this have been across the four
decades of assisted reproductive technology helping people become parents. That
is true. And they will talk about the Australian system being extremely robust
on international comparisons.
But people
are people. And two incidents reported within two months of each other, both at
the same company, will have anxiety levels rising.
“The reaction
was very quick and very strong from both my clients and also my followers on
Instagram, just: ‘Oh my gosh, how does this happen again?’ ” former
clinical embryologist and IVF patient advocate Lucy Lines told the ABC.
“(It ranged)
from people who’ve completed their families with IVF, who are at home with
their children and now feel anxious about whether they need to do DNA testing,
through to people who are currently having treatment, maybe they just had a
transfer or they’re about to have a transfer, feeling very anxious about that.
“I’m not
trying to be dramatic but I’m like, I don’t trust (our frozen embryos) sitting
in that freezer at the moment … It just made me think last night, well, I think
we need to speed up that conversation about what we want to do with them
because at the moment I don’t trust the current situation”
“And even
people who are looking down the barrel of doing IVF, already feeling anxious
about it as it is, and now that anxiety has been ramped up a whole lot of
levels.”
Hawkins says
his trust has been shaken. “I’m not trying to be dramatic but I’m like, I don’t
trust (our frozen embryos) sitting in that freezer at the moment … It just made
me think last night, well, I think we need to speed up that conversation about
what we want to do with them because at the moment I don’t trust the current
situation.”
Swinburne
University of Technology senior lecturer of health promotion Evie Kendal also
raises the issue of trust in the current system.
“By
introducing more areas of human intervention into reproduction, such
technologies also introduce the potential for human error, as has been seen in
these cases,” Kendal says.
“Previous
safeguards are clearly not up to the challenge of protecting clients against
such incidents, and urgent ethical and policy guidance is needed to prevent
such mistakes from occurring again.”
Consultant
obstetrician Alex Polyakov says it is important to remember that IVF clinics in
Australia “operate within some of the most highly regulated and scrutinised
environments in medicine”.
“Australia’s
assisted reproductive sector is internationally recognised for its rigorous
oversight and quality control,” Polyakov says.
“In over 40
years of IVF practice in Australia, these events remain statistical outliers –
still extraordinarily uncommon. However, their emotional and ethical
implications are significant, and concern among patients is entirely
understandable.”
Practitioners
are battling privately with ethical and practice challenges in the wake of
these errors.
Inquirer
understands that questions have been raised about whether the obligations of
Monash IVF, a listed company, to notify the ASX of events that may affect its
share price have overridden the ethical obligation of a doctor to provide
appropriate care and welfare of their patient, including confidentiality where
necessary.
While the
families involved in these incidents have not been named publicly, seeing the
matter raised in the public domain in any event would be emotionally difficult,
medical practitioners say.
Monash IVF
was criticised in April for not reporting the Brisbane incident to the ASX in a
timely manner and was much quicker to report the latest Melbourne error.
A further
conundrum for specialists in this field is whether they should now include the
remote possibility of an embryo mix-up as part of their informed consent
process.
Monash IVF’s
embryo mix-ups clearly have dented trust across the assisted reproductive
technology sector, and in such an emotionally charged area winning it back will
be hard. It is vital that work is done. The hopes and dreams of so many
families depend on it.
Here is the link:
https://www.theaustralian.com.au/health/medical/weird-and-icky-feeling-anxiety-for-parents-after-monash-ivf-embryo-bungles/news-story/c38c936b82a6421d73b160c75d2d730d
We all know being 100% error free is
a very high bar, to say the least, but avoiding errors must be pretty much
certain or the industry will loose its social license!
This just means that both the systems
and the people involved have to try really hard and get the error rates as close
to zero as possible, and all the supportive tricks needed to make systems reliable need to
be implemented and monitored.
To achieve this all the techniques
of error prevention need to be brought into play and vigorously applied with
everyone understanding the responsibility they carry! A tall ask but the best
we can do, being human! Careful study of airline systems would be a good place to start!
David.